These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28541237)

  • 1. Treatment decision-making capacity in hospitalized patients with schizophrenia.
    Bilanakis N; Peritogiannis VK; Vratsista A
    Psychiatriki; 2017; 28(1):37-45. PubMed ID: 28541237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the French Version of the MacArthur Competence Assessment Tool for Treatment (MacCAT-T) in a French Sample of Individuals with Schizophrenia: Validation de la version française de l'instrument d'évaluation des compétences MacArthur-traitement (MacCAT-T) dans un échantillon français de personnes souffrant de schizophrénie.
    Raffard S; Lebrun C; Laraki Y; Capdevielle D
    Can J Psychiatry; 2021 Apr; 66(4):395-405. PubMed ID: 33064578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment decision-making capacity in non-consensual psychiatric treatment: a multicentre study.
    Mandarelli G; Carabellese F; Parmigiani G; Bernardini F; Pauselli L; Quartesan R; Catanesi R; Ferracuti S
    Epidemiol Psychiatr Sci; 2018 Oct; 27(5):492-499. PubMed ID: 28274298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Decision-Making Capacity in Children and Adolescents Hospitalized for an Acute Mental Disorder: The Role of Cognitive Functioning and Psychiatric Symptoms.
    Mandarelli G; Sabatello U; Lapponi E; Pace G; Ferrara M; Ferracuti S
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):462-465. PubMed ID: 27935747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive insight as an indicator of competence to consent to treatment in schizophrenia.
    Raffard S; Fond G; Brittner M; Bortolon C; Macgregor A; Boulenger JP; Gely-Nargeot MC; Capdevielle D
    Schizophr Res; 2013 Mar; 144(1-3):118-21. PubMed ID: 23313358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia.
    Palmer BW; Dunn LB; Appelbaum PS; Jeste DV
    Arch Gen Psychiatry; 2004 Mar; 61(3):230-6. PubMed ID: 14993110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopathology, psychopharmacological properties, decision-making capacity to consent to clinical research and the willingness to participate among long-term hospitalized patients with schizophrenia.
    Wu BJ; Liao HY; Chen HK; Lan TH
    Psychiatry Res; 2016 Mar; 237():323-30. PubMed ID: 26847945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competence to consent and insight in schizophrenia: is there an association? A pilot study.
    Capdevielle D; Raffard S; Bayard S; Garcia F; Baciu O; Bouzigues I; Boulenger JP
    Schizophr Res; 2009 Mar; 108(1-3):272-9. PubMed ID: 19162443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between executive functions and capacity to consent to treatment in acute psychiatric hospitalization.
    Mandarelli G; Parmigiani G; Tarsitani L; Frati P; Biondi M; Ferracuti S
    J Empir Res Hum Res Ethics; 2012 Dec; 7(5):63-70. PubMed ID: 23324205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary Turkish study of psychiatric in-patients' competence to make treatment decisions.
    Aydin Er R; Sehiralti M; Aker AT
    Asia Pac Psychiatry; 2013 Mar; 5(1):E9-E18. PubMed ID: 23857795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill, and non-ill subjects.
    Candilis PJ; Fletcher KE; Geppert CM; Lidz CW; Appelbaum PS
    Schizophr Res; 2008 Feb; 99(1-3):350-8. PubMed ID: 18164593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing capacity to consent to treatment with cholinesterase inhibitors in dementia using a specific and standardized version of the MacArthur Competence Assessment Tool (MacCAT-T).
    Mueller T; Haberstroh J; Knebel M; Oswald F; Kaspar R; Kemper CJ; Halder-Sinn P; Schroeder J; Pantel J
    Int Psychogeriatr; 2017 Feb; 29(2):333-343. PubMed ID: 27825402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MacArthur Competence Assessment Tools for assessing decision-making capacity in schizophrenia: A meta-analysis.
    Wang SB; Wang YY; Ungvari GS; Ng CH; Wu RR; Wang J; Xiang YT
    Schizophr Res; 2017 May; 183():56-63. PubMed ID: 27876273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capacity of forensic patients to consent to research: the use of the MacCAT-CR.
    McDermott BE; Gerbasi JB; Quanbeck C; Scott CL
    J Am Acad Psychiatry Law; 2005; 33(3):299-307. PubMed ID: 16186191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competence to consent to research among long-stay inpatients with chronic schizophrenia.
    Kovnick JA; Appelbaum PS; Hoge SK; Leadbetter RA
    Psychiatr Serv; 2003 Sep; 54(9):1247-52. PubMed ID: 12954941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Chinese version of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) in patients with schizophrenia spectrum disorders.
    Lan TH; Wu BJ; Chen HK; Liao HY; Lee SM; Sun HJ
    Psychiatry Res; 2013 Dec; 210(2):634-40. PubMed ID: 23928212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical patients' treatment decision making capacity: a report from a general hospital in Greece.
    Bilanakis N; Vratsista A; Athanasiou E; Niakas D; Peritogiannis V
    Clin Pract Epidemiol Ment Health; 2014; 10():133-9. PubMed ID: 25505489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.
    Stroup S; Appelbaum P; Swartz M; Patel M; Davis S; Jeste D; Kim S; Keefe R; Manschreck T; McEvoy J; Lieberman J
    Schizophr Res; 2005 Dec; 80(1):1-8. PubMed ID: 16182516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing decision-making competency of schizophrenia participants in clinical trials. A meta-analysis and meta-regression.
    Hostiuc S; Rusu MC; Negoi I; Drima E
    BMC Psychiatry; 2018 Jan; 18(1):2. PubMed ID: 29304845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the capacity of inpatients with chronic schizophrenia to provide informed consent for participation in clinical trials; use of the Hebrew version of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR).
    Linder M; Lev-Ari L; Kurs R; Melamed Y
    Isr Med Assoc J; 2012 Aug; 14(8):470-4. PubMed ID: 22977964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.